Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning

被引:43
作者
Modanlou, HD
Gharraee, Z
Hasan, J
Waltzman, J
Nageotte, S
Beharry, KDA
机构
[1] Univ Calif Irvine, Med Ctr, Div Neonatal Perinatal Med, Orange, CA 92868 USA
[2] Miller Childrens Hosp, Div Neonatal Perinatal Med, Long Beach, CA USA
[3] Mem Hlth Serv Res Ctr, Long Beach, CA USA
关键词
D O I
10.1167/iovs.05-1046
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF)-I, and growth hormone (GH) are major regulators of physical growth, as well as normal and pathologic retinal development. Ocular tissues are protected by the blood-ocular barrier. This study was conducted to test the hypothesis that the ontogenic profiles of VEGF, IGF-I, and GH in the rat serum, vitreous fluid, and retina are compartment specific, and that the vitreous is a reservoir for retinal growth factors. METHODS. Sprague-Dawley rat pups were killed at birth (postnatal day [P] 0) and at P7, P14, and P21. At death, serum, vitreous fluid, and retinal homogenates were analyzed for ontogeny of VEGF, IGF-I, and GH. RESULTS. VEGF levels were 10 times higher in the vitreous than in serum at all stages of development. Vitreous and serum VEGF levels progressively declined, with lowest concentrations at P21. Retinal VEGF levels increased with the highest concentration at P21. IGF-I levels in the vitreous decreased from P7 through P21. IGF-I levels in serum and retinal homogenates increased with advancing postnatal age. Although IGF-I levels were four times higher in the vitreous than in the retina at P0, equilibration was achieved at P21. GH levels in the vitreous were 10 times lower than serum levels, were decreased at P14 and P21, and remained unchanged from P0 through P21 in the retina. CONCLUSIONS. VEGF and IGF-I act in concert to promote retinal development with the vitreous fluid as a reservoir. The ontogenic profiles of VEGF, IGF-I and GH in the serum and ocular compartments are specific. These differences should be considered when therapies for ROP are proposed.
引用
收藏
页码:738 / 744
页数:7
相关论文
共 48 条
  • [1] SUPPRESSION OF RETINAL NEOVASCULARIZATION IN-VIVO BY INHIBITION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR (VEGF) USING SOLUBLE VEGF-RECEPTOR CHIMERIC PROTEINS
    AIELLO, LP
    PIERCE, EA
    FOLEY, ED
    TAKAGI, H
    CHEN, H
    RIDDLE, L
    FERRARA, N
    KING, GL
    SMITH, LEH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) : 10457 - 10461
  • [2] VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS
    AIELLO, LP
    AVERY, RL
    ARRIGG, PG
    KEYT, BA
    JAMPEL, HD
    SHAH, ST
    PASQUALE, LR
    THIEME, H
    IWAMOTO, MA
    PARK, JE
    NGUYEN, HV
    AIELLO, LM
    FERRARA, N
    KING, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) : 1480 - 1487
  • [3] VASCULAR ENDOTHELIAL GROWTH-FACTOR ACTS AS A SURVIVAL FACTOR FOR NEWLY FORMED RETINAL-VESSELS AND HAS IMPLICATIONS FOR RETINOPATHY OF PREMATURITY
    ALON, T
    HEMO, I
    ITIN, A
    PEER, J
    STONE, J
    KESHET, E
    [J]. NATURE MEDICINE, 1995, 1 (10) : 1024 - 1028
  • [4] DISTRIBUTION OF IGF-I AND IGF-II, IGF BINDING-PROTEINS (IGFBPS) AND IGFBP MESSENGER-RNA IN OCULAR FLUIDS AND TISSUES - POTENTIAL SITES OF SYNTHESIS OF IGFBPS IN AQUEOUS AND VITREOUS
    ARNOLD, DR
    MOSHAYEDI, P
    SCHOEN, TJ
    JONES, BE
    CHADER, GJ
    WALDBILLIG, RJ
    [J]. EXPERIMENTAL EYE RESEARCH, 1993, 56 (05) : 555 - 565
  • [5] EFFECT OF OXYGEN ON DEVELOPING RETINAL VESSELS WITH PARTICULAR REFERENCE TO THE PROBLEM OF RETROLENTAL FIBROPLASIA
    ASHTON, N
    WARD, B
    SERPELL, G
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1954, 38 (07) : 397 - 432
  • [6] ASHTON N, 1996, AM J OPHTHALMOL, V2, P412
  • [7] Fetal growth and placental function
    Bauer, MK
    Harding, JE
    Bassett, NS
    Breier, BH
    Oliver, MH
    Gallaher, BH
    Evans, PC
    Woodall, SM
    Gluckman, PD
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1998, 140 (1-2) : 115 - 120
  • [8] Vitreous levels of vascular endothelial growth factor are not influenced by its serum concentrations in diabetic retinopathy
    Burgos, R
    Simo, R
    Audi, L
    Mateo, C
    Mesa, J
    GarciaRamirez, M
    Carrascosa, A
    [J]. DIABETOLOGIA, 1997, 40 (09) : 1107 - 1109
  • [9] Effects of angiogenic growth factor combinations on retinal endothelial cells
    Castellon, R
    Hamdi, HK
    Sacerio, I
    Aoki, AM
    Kenney, MC
    Ljubimov, AV
    [J]. EXPERIMENTAL EYE RESEARCH, 2002, 74 (04) : 523 - 535
  • [10] Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?
    Chow, LC
    Wright, KW
    Sola, A
    [J]. PEDIATRICS, 2003, 111 (02) : 339 - 345